Ribavirin (Oceanside Pharmaceuticals)
Welcome to the PulseAid listing for the Ribavirin drug offered from Oceanside Pharmaceuticals. This Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Oceanside Pharmaceuticals |
NON-PROPRIETARY NAME: | Ribavirin |
SUBSTANCE NAME: | RIBAVIRIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] |
ROUTE: | RESPIRATORY (INHALATION) |
DOSAGE FORM: | POWDER, FOR SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2017-04-14 |
END MARKETING DATE: | 0000-00-00 |
Ribavirin HUMAN PRESCRIPTION DRUG Details:
Item Description | Ribavirin from Oceanside Pharmaceuticals |
LABELER NAME: | Oceanside Pharmaceuticals |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 6(g/1) |
START MARKETING DATE: | 2017-04-14 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68682-019_1bd850c4-a638-4143-b6be-0c50521a0449 |
PRODUCT NDC: | 68682-019 |
APPLICATION NUMBER: | NDA018859 |
Other RIBAVIRIN Pharmaceutical Manufacturers / Labelers: